• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Mild traumatic brain injury associated with detectably neuroimaging changes and depressive symptoms

bySimon PanandAlex Chan
October 3, 2024
in Chronic Disease, Neurology, Psychiatry
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. A history of mild traumatic brain injury (TBI) in healthy, middle-aged adults was associated with detectable changes in neuroimaging and clinical outcomes such as poorer sleep and depressive symptoms.

Evidence Rating Level: 2 (Good)

Study Rundown: While TBI has been recognized as a risk factor for dementia, the precise mechanisms linking the two processes are not well understood. Vascular injury, such as cerebral microbleeds (CMB), is a common pathology that arises from TBI. However, the influence of TBI history on the associations between CMB and vascular risk factors and observable clinical deficits has not been well established. This study therefore sought to investigate the association between TBI history and observable neuroimaging and clinical features in middle-aged adults.

In this cross-sectional study, 617 participants between 40 and 59 years of age with no existing cognitive impairments were assessed for CMB and imaging markers of small vessel disease (SVD) via 3T MRI. Cognitive performance, TBI history and cardiovascular disease (CVD) risk were each assessed. CMB were not found to be related to CVD risk, but were associated with history of TBI. Greater number of TBI events was also associated with clinical deficits such as poorer sleep, gait disturbances and increased depressive symptoms.

Overall, this study found that a history of TBI was associated with detectable changes in brain imaging as early as midlife in otherwise healthy adults, supporting the mechanism of vascular injury as a possible link between TBI and neurodegenerative processes.

Click to read the study in JAMA Network Open

RELATED REPORTS

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

Relevant Reading: Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury

In-Depth [cross-sectional study]: While TBI has been recognized as a risk factor for dementia, the pathophysiological mechanisms connecting the two processes are not well understood. Vascular injury is a common pathology that arises from TBI, with cerebral microbleeds (CMB) representing a possible consequence of TBI and a marker for cerebral small vessel disease (SVD). However, TBI has rarely been considered as a cause of CMB in the study of SVD, leading to inconsistencies in the association between CMB and other established correlates of SVD such as vascular risk factors including hypertension. This study therefore sought to investigate the association between lifetime TBI history and early SVD, as well as TBI history and CMB and other measurable vascular risk factors.

617 participants (median [IQR] age, 52 [47-56] years) between 40 and 59 years of age and cognitively healthy were assessed for CMB and imaging markers of SVD via 3T MRI. Cognitive performance was assessed using the Computerized Assessment of Information Processing (COGNITO) battery. TBI history and cardiovascular disease (CVD) risk were also assessed using the Brain Injury Screening Questionnaire (BISQ) and the Framingham Risk Score respectively. CMB were found to be associated with greater age (β = 0.07; 95% CI, 0.03-0.11) but were not related to CVD risk. CMB were greater in individuals with a history of TBI compared to participants without TBI history, with an observed dose-response association between CMB and increasing number of TBI events (95% CI, 0.01-0.09). In interaction analyses, the association between CMB and greater CVD risk was found to be lower with increasing number of TBI events. History of TBI events was also associated with clinical deficits including worse sleep quality and greater depressive symptoms, but not cognition.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: chronic diseaseConcussionneurologypsychiatrytbi
Previous Post

Bayer’s Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure

Next Post

Tulisokibart effectively induces clinical remission in moderately to severely active ulcerative colitis

RelatedReports

Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Chronic Disease

Positive psychotherapy may be similarly effective to traditional cognitive behavioural therapy for panic disorder

August 21, 2026
Next Post
Elective colectomy associated with improved survival in ulcerative colitis

Tulisokibart effectively induces clinical remission in moderately to severely active ulcerative colitis

Shared decision-making may be limited in PICU end-of-life discussions

Digital cognitive therapy program may be effective for alcohol use disorder

#VisualAbstrcat: Lamotrigine and Mexiletine Treatments Resulted in Similar Improvements for Non-Dystrophic Myotonias

#VisualAbstrcat: Lamotrigine and Mexiletine Treatments Resulted in Similar Improvements for Non-Dystrophic Myotonias

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
  • Large language models (LLMs) demonstrated the ability to generate accurate research manuscripts but required human oversight for more complex analyses
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.